932013-45-1 Usage
Uses
Used in Pharmaceutical Applications:
(R)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine oxalate is used as a potential ligand for sigma-2 receptors in the pharmaceutical industry. Its interaction with these receptors may contribute to the development of new therapeutic strategies for various conditions.
Used in Anticancer Research:
In the field of oncology, (R)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine oxalate is being studied for its potential anti-cancer properties. Its ability to target sigma-2 receptors may play a role in inhibiting tumor growth and progression, making it a promising candidate for further research and development in cancer treatment.
Used in Neuroprotective Studies:
(R)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine oxalate is also being investigated for its potential neuroprotective activities. As a sigma-2 receptor ligand, it may offer protective effects against neurodegenerative diseases by modulating cellular processes and reducing neuronal damage.
Check Digit Verification of cas no
The CAS Registry Mumber 932013-45-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,2,0,1 and 3 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 932013-45:
(8*9)+(7*3)+(6*2)+(5*0)+(4*1)+(3*3)+(2*4)+(1*5)=131
131 % 10 = 1
So 932013-45-1 is a valid CAS Registry Number.
932013-45-1Relevant academic research and scientific papers
DNT-MALEATE AND METHODS OF PREPARATION THEREOF
-
Page/Page column 19, (2010/11/26)
(S)-N,N-Dimethyl-3-(l-naphtlialenyloxy)-3-(2-thienyl)propanamine nialeate (DNT-maleate) and polymorphs of DNT-maleate, compositions of DNT-maleate and its polymorphs, processes for the preparation of DNT-maleate and its polymorphs, and processes for the preparation of duloxetine hydrochloride from DNT-maleate are provided.
DNT-FUMARATE AND METHODS OF PREPARATION THEREOF
-
Page/Page column 15, (2008/06/13)
(S)-N,N-Dimethyl-3-(l-naphthalenyloxy)-3-(2-thienyl)propanamine fumarate (DNT-fumarate) and polymorphs of DNT-fumarate, compositions of DNT-fumarate and its polymorphs, processes for the preparation of DNT-fumarate and its polymorphs, and processes for the preparation of duloxetine hydrochloride from DNT-fumarate are provided.
